A Tanaka, JD Jensen, R Prado, H Riemann… - Gene Therapy, 2011 - nature.com Malignant melanoma is one of the deadliest forms of skin cancer and its incidence is expected to rise over the next two decades. At present, there are no effective therapies for advanced melanoma. We have previously shown that administration of whole recombinant yeast ... Cited by 3 - All 3 versions
HG Yang, BL Hu, L Xiao… - Cancer Gene Therapy, 2011 - nature.com ... Cancer Gene Therapy 18, 370-380 (May 2011) | doi :10.1038/cgt.2011.13. ... Importantly, direct injection of this engineered lentivector inhibited the growth of aggressive B16 murine melanoma ... suggest that DC-specific lentivectors can be a novel and alternative vaccine carrier with ... All 3 versions
[HTML] from hindawi.comZ Fengrong, S Xiuqin, W Xing'an… - Evidence-Based …, 2011 - hindawi.com ... We demonstrated that a genetically engineeredvaccine encoding the LCDV MCP gene elicited significant levels of protective LCDV-specific immunity, the levels of which were dose dependent and roughly proportional to the amount of protection conferred. ... Cached
NM Beach, SM Smith, S Ramamoorthy… - Journal of …, 2011 - Am Soc Microbiol ... A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against ... A genetically engineered chimeric vaccine against porcine ... Related articles - All 4 versions
[PDF] from cnic.org.cnM Abt, J de Jonge, M Laue… - Vaccine, 2011 - cnic.org.cn ... obstacle. Influenza vaccine viruses usually consist of two segments coding for the antigenic HA and NA proteins of a wild-type strain and the six residual internal gene segments of the vaccine donor strain A/PR/8/34 (PR8). To ... View as HTML - All 2 versions